Form D · Other Technology
Onyx Bio, Inc.
Berkeley, CA · CIK 0001915234
Offering snapshot reported Feb 26, 2026 · SEC filing
- Reported sold
- $8M Offering amount: $8M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 26, 2026 | Initial | $7,999,999 | No comparison | 3 | SEC filing |
| Mar 22, 2022 | Initial | $5,326,957 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-574690
Source: Form D, filed Feb 26, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Roger Chen | Director, Executive |
| Lance C. Coleman | Director, Executive, Promoter |
| Amit Lakhani | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
626 Bancroft Way Suite A
Berkeley, CA, 94710
Berkeley, CA, 94710